title: Is adjuvant therapy with three-dimensional conformal irradiation combined with capecitabine (Xeloda) for gastric cancer effective?
authors.forename: K
authors.initials: K
authors.lastname: Pistevou-Gompaki
authors.forename: V
authors.initials: V
authors.lastname: Kouloulias
authors.forename: C
authors.initials: C
authors.lastname: Papaloukas
authors.forename: D
authors.initials: D
authors.lastname: Eleftheriadis
authors.forename: I
authors.initials: I
authors.lastname: Andronikidis
authors.forename: N
authors.initials: N
authors.lastname: Eleftheriadis
authors.forename: D
authors.initials: D
authors.lastname: Bitzilekis
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D008875:Middle Aged; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D020266:Radiotherapy, Conformal; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil